Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 39 | 48 | +9 |
| Shares | 4.16M | 3.97M | −190.1K (−4.6%) |
| Value | $14.0M | $11.0M | −$2.97M (−21.3%) |
New holders (11)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Liberty Wealth Management LLC | 30,000 | $82.0K | 0.03% |
| Virtu Financial LLC | 20,702 | $57.0K | 0.00% |
| Renaissance Technologies LLC | 17,100 | $47.0K | 0.00% |
| HighPoint Advisor Group LLC | 17,033 | $45.0K | 0.00% |
| Jane Street Group, LLC | 12,085 | $33.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 5,544 | $15.0K | 0.00% |
| Bangor Savings Bank | 4,000 | $11.0K | 0.00% |
| Harbour Investments, Inc. | 2,634 | $7.00K | 0.00% |
| Cypress Capital Management LLC (WY) | 1,000 | $3.00K | 0.00% |
| FMR LLC | 35 | $0 | 0.00% |
| CoreCap Advisors, LLC | 133 | $0 | 0.00% |
Sold out (2)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| CFO4Life Group, LLC | 12,000 | $40.0K |
| Two Sigma Advisers, LP | 11,000 | $37.0K |